TY - JOUR
T1 - Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway
AU - Feng, Weijun
AU - Webb, Paul
AU - Nguyen, Phuong
AU - Liu, Xiaohong
AU - Li, Jiandong
AU - Karin, Michael
AU - Kushner, Peter J.
PY - 2001
Y1 - 2001
N2 - Estrogen receptor (ER) is activated either by ligand or by signals from tyrosine kinase-linked cell surface receptors. We investigated whether the nonreceptor Src tyrosine kinase could affect ER activity. Expression of constitutively active Src or stimulation of the endogenous Src/JNK pathway enhances transcriptional activation by the estrogen-ER complex and strongly stimulates the otherwise weak activation by the unliganded ER and the tamoxifen-ER complex. Src affects ER activation function 1 (AF-1), and not ER AF-2, and does so through its tyrosine kinase activity. This effect of Src is mediated partly through a Raf/mitogen-activated ERK kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) signaling cascade and partly through a MEKK/JNKK/JNK cascade. Although, as previously shown, Src action through activated ERK stimulates AF-1 by phosphorylation at S118, Src action through activated JNK neither leads to phosphorylation of S118 nor requires S118 for its action. We therefore suggest that the Src/JNK pathway enhances AF-1 activity by modification of ER AF-1-associated proteins. Src potentiates activation functions in CREB-binding protein (CBP) and glucocorticoid receptor interacting protein 1 (GRIP1), and we discuss the possibility that the Src/JNK pathway enhances the activity of these co-activators, which are known to mediate AF-1 action.
AB - Estrogen receptor (ER) is activated either by ligand or by signals from tyrosine kinase-linked cell surface receptors. We investigated whether the nonreceptor Src tyrosine kinase could affect ER activity. Expression of constitutively active Src or stimulation of the endogenous Src/JNK pathway enhances transcriptional activation by the estrogen-ER complex and strongly stimulates the otherwise weak activation by the unliganded ER and the tamoxifen-ER complex. Src affects ER activation function 1 (AF-1), and not ER AF-2, and does so through its tyrosine kinase activity. This effect of Src is mediated partly through a Raf/mitogen-activated ERK kinase/extracellular signal-regulated kinase (Raf/MEK/ERK) signaling cascade and partly through a MEKK/JNKK/JNK cascade. Although, as previously shown, Src action through activated ERK stimulates AF-1 by phosphorylation at S118, Src action through activated JNK neither leads to phosphorylation of S118 nor requires S118 for its action. We therefore suggest that the Src/JNK pathway enhances AF-1 activity by modification of ER AF-1-associated proteins. Src potentiates activation functions in CREB-binding protein (CBP) and glucocorticoid receptor interacting protein 1 (GRIP1), and we discuss the possibility that the Src/JNK pathway enhances the activity of these co-activators, which are known to mediate AF-1 action.
UR - http://www.scopus.com/inward/record.url?scp=0035134504&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035134504&partnerID=8YFLogxK
U2 - 10.1210/mend.15.1.0590
DO - 10.1210/mend.15.1.0590
M3 - Article
C2 - 11145737
AN - SCOPUS:0035134504
VL - 15
SP - 32
EP - 45
JO - Molecular Endocrinology
JF - Molecular Endocrinology
SN - 0888-8809
IS - 1
ER -